Customer Education

Webinar: SygRNA®-Synthetic Two Part CRISPR RNA System

Webinar Title: SygRNA®-Synthetic Two Part CRISPR RNA System

 Abstract

The CRISPR/Cas genome editing system has revolutionized most every aspect of the life science industry. Until recently, the most used formats for this technology have been plasmids, mRNA, or lentivirus. Each reagent has been successful in its own right, however, each approach has limitations. SygRNA®, the two-part synthetic crRNA and tracrRNA, increases the pace of research, decreases costs, and can be used with Cas9 protein, Cas9 mRNA and Cas9 expressing cells/models.

This webinar discusses the development of the SygRNA® system, protocol optimization, and proposes workflows that enable scientists to quickly incorporate CRISPR technologies into their research.
 

 What Will You Learn?

  • SygRNA® is a cost effective, fast and efficient tool for gene editing.
  • SygRNA® alleviates issues associated with random integration and observed stress/toxicity.
  • SygRNA® removes the need for cloning and careful promoter choice.
  • SygRNA® negates post IVT sgRNA sequencing.
  • SygRNA® can be used with multiple formats of Cas9 protein.
  • SygRNA® can be chemically modified.
  • SygRNA® production can be scaled up easily.

 

Speaker Bio
Dr. Gurpreet Singh Balrey
Global Technical Applications Manager at Merck KGaA, Darmstadt, Germany
Gurpreet Balrey is a Global Technical Applications Manager at Merck focusing on custom products. He attended the University of Nottingham for a Biotechnology degree followed by a PhD in Molecular Biology and Plant Genetic Engineering at the same University. Gurpreet has held various positions within the technical sales team during his 8 years at Merck. He has particularly been involved in working with the Welcome Trust Sanger Institute to bring the arrayed whole genome libraries to market and more currently on our SygRNA synthetic two part CRISPR RNA offering.